{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:23:42Z","timestamp":1760243022799},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,11,15]]},"DOI":"10.2169\/internalmedicine.0737-18","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T22:28:54Z","timestamp":1542234534000},"page":"3249-3254","source":"Crossref","is-referenced-by-count":7,"title":["Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma"],"prefix":"10.2169","volume":"57","author":[{"given":"Sho","family":"Ishigaki","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Masaoka","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisako","family":"Kameyama","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Kawaida","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Kameyama","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58: 15-25, 2008.","DOI":"10.1002\/art.23177"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Upchurch KS, Kay J. Evolution of treatment for rheumatoid arthritis. Rheumatology (Oxford)  51 (Suppl): vi28-vi36, 2012.","DOI":"10.1093\/rheumatology\/kes278"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yamanaka H, Inoue E, Tanaka E, et al. Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA). Mod Rheumatol 17: 98-105, 2007.","DOI":"10.3109\/s10165-006-0546-7"},{"key":"4","unstructured":"4. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."},{"key":"5","unstructured":"5. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. WHO Press, Geneva, 2017: 462-464."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kato E, Sawada T, Tahara K, et al. The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study. Int J Rheum Dis 20: 839-845, 2017.","DOI":"10.1111\/1756-185X.12998"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Satoh K, Yoshida N, Imaizumi K, et al. Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis. Am J Med Sci 338: 334-335, 2009.","DOI":"10.1097\/MAJ.0b013e3181acbb49"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ikeda K, Nakamura T, Kinoshita T, et al. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation. Clin J Gastroenterol 9: 17-21, 2016.","DOI":"10.1007\/s12328-015-0624-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nishizawa T, Suzuki H, Fujimoto A, et al. Effects of patient age and choice of antisecretory agent on success of eradication therapy for <i>Helicobacter pylori<\/i> infection. J Clin Biochem Nutr 60: 208-210, 2017.","DOI":"10.3164\/jcbn.16-86"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for <i>Helicobacter pylori<\/i> eradication: a phase III, randomised, double-blind study. Gut 65: 1439-1446, 2016.","DOI":"10.1136\/gutjnl-2015-311304"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zullo A, Hassan C, Cristofari F, et al. Effects of <i>Helicobacter pylori<\/i> eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 8: 105-110, 2010.","DOI":"10.1016\/j.cgh.2009.07.017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Oka K, Shinonaga M, Nagayama R, et al. Coexistence of primary pulmonary Hodgkin lymphoma and gastric MALT lymphoma associated with Epstein-Barr virus infection: a case report. Pathol Int 60: 520-523, 2010.","DOI":"10.1111\/j.1440-1827.2010.02554.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chan WY, Chan EK, Chow JH. Epstein-Barr virus-associated gastric lymphomas are distinct from mucosa-associated lymphoid tissue-type lymphomas: genetic abnormalities of p53 gene. Diagn Mol Pathol 10: 153-160, 2001.","DOI":"10.1097\/00019606-200109000-00002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hasserjian RP, Chen S, Perkins SL, et al. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol 22: 1532-1540, 2009.","DOI":"10.1038\/modpathol.2009.131"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91: 20-28, 2013.","DOI":"10.1111\/ejh.12116"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Matsui Y, Miura Y, Sugino N, Kaneko H, Watanabe M, Tsudo M. Methotrexate-associated lymphoplasmacytic lymphoma complicated with type 2 cryoglobulinemia. Int J Hematol 93: 253-256, 2011.","DOI":"10.1007\/s12185-010-0749-8"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Mariette X, Cazals-Hatem D, Warszawki J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99: 3909-3915, 2002.","DOI":"10.1182\/blood.V99.11.3909"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Saito S, Kaneko Y, Yamaoka K, Tokuhira M, Takeuchi T. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatology (Oxford) 56: 940-946, 2017.","DOI":"10.1093\/rheumatology\/kex002"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/22\/57_0737-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T05:38:55Z","timestamp":1542433135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/22\/57_0737-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":18,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0737-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]}}}